±ØÍþBETWAY

ȪԴ£ºÖÐԭ֤ȯ  £¬×÷Õߣº  £¬£º

ÚÀ  £¬ÄãÏþµÃ²»  £¬Õ⡸¸¶·ÑЧÀÍͬ³ÇÉÏÃÅ¡¹×î½üÒ°Ê¢ÐÐ

ÎÒ¸úÄã½²àë  £¬Ç°Õó×ÓÎÒÈ¥ßTßT  £¬ÌýµêÀïÂô²èµÄÀÏ»õ×н²ÆðÕâ¸ö¡¸¸¶·ÑЧÀÍͬ³ÇÉÏÃÅ¡¹  £¬½²µÃÊÇÈÈÄÖ¡£ÏÖʱ½Ú  £¬½¨ê±È˃ÓÂÛÊÇÒªÐÞ¿Õµ÷¡¢ÇåË®¹Ü  £¬Õվɽиöʦ¸µÀ´»»µÆµ¨  £¬ÕâЩʶ¼¿ÉÒÔÉÏÃÅ×öâ·½â¾ö  £¬Àû±ãµÃºÜ¡£Äã½²ÊǃÓÊÇ£¿

Ïà¹ØÍ¼Æ¬

¿ÉÊÇàë  £¬ÎÒ¿´Ò°¶àÈ˶ÔÕâ¸öÉÏÃÅЧÀÍÓÐÎó»á  £¬ÒÔΪÂï  £¬¸¶µãÇ®¾Í°²ÄؼòÆÓ¡£×Åʵ°¡  £¬ÕâÀïÍ·ÓÐÃŵÀÁ¨  £¬ƒÓŪÃ÷È·µÄ»°  £¬¿ÉÄܾͻáÓöµ½¿Ó¡£½ñÌìÂï  £¬ÎÒ¾ÍÀ´¸úÄã½²½²Õâ¸öÊ  £¬ÕÕÎÒ¿´Á¨  £¬ÕÕ¾ÉÂùÖµµÃÏþµÃÒ»¶þµÄ¡£

ÉÏÃÅЧÀ͵ÄÃŵÀ  £¬±ð¿´¼òÆÓ  £¬ÍäÀ´ÍäÈ¥ÏñÀÏÏï×Ð

ÎÒºóÉúʱ½Úàë  £¬ÄÄÓÐÕâЩ¡¸¸¶·ÑЧÀÍͬ³ÇÉÏÃÅ¡¹£¿ÄÇ»á¶ù  £¬°³½¨ê±È˼ÒÀïË®¹Ü»µÁË  £¬µÆµ¨ÉÕÁË  £¬¶¼ÊÇ×Ô¼ÒÐÞÀí  £¬»òÕßÍÐÁÚÈË×ÊÖú  £¬×öâ·½â¾ö¡£ÏÖʱ½ÚÂï  £¬Àû±ãÒ°¶àÁ¨  £¬Î¢ÐÅ¡¢APPµãµã¾ÍÓÐÈËÉÏÃÅÀ´×ÊÖú  £¬Ê²Ø±¶¼Äܽâ¾ö¡£

¿ÉÊÇàë  £¬Àû±ã¹éÀû±ã  £¬Õâ¸öÊÂÒ²ƒÓÄÜÌ«Ëæ±ã¡£ÄãÏëÂï  £¬ÀϳÇÏï×ÐÀïÍäÀ´ÍäÈ¥  £¬×ß´íÒ»²½¾ÍÈÆÔ¶ÁË¡£ÕâÉÏÃÅЧÀÍÒ²ÊÇÒ»Ñù  £¬ÓÐЩµØ·½Òª×¢ÖØ¡£ºÃ±ÈÂï  £¬Ê¦¸µÉÏÃÅǰ  £¬ÄãµÃÎÊÇåÎúÊշѱê×¼Á¨  £¬ƒÓÈ»¿ÉÄÜÊյñȹâ±ýµêÒ»´ó¶Ñ¹â±ý»¹¹ó¡£

Ïà¹ØÍ¼Æ¬
ÚÀ  £¬ÎÒ͵͵¸úÄã½²àë  £¬ÓиöÇÏÃÅ£º½ÐÉÏÃÅЧÀÍ  £¬×îºÃÑ¡ÄÇÖÖÓÐÍâµØ¿Ú±®µÄʦ¸µ¡£½¨ê±ÈËÂï  £¬¿¼¾¿¸öÊìÈËÏÈÈÝ  £¬ÄÄ¿é×ö¹ýµÄ  £¬¸÷È˶¼ÏþµÃºÃÇ·ºÃ¡£ÉÐÓÐÁ¨  £¬±ð̰×ÔÖÆ  £¬¼ÛǮ̫µÍµÄ  £¬¿ÉÄܾÍÊÇ¿Ó  £¬Äã½²ÊǃÓÊÇ£¿

ÉÐÓÐÒ»µã  £¬ÎÒÒ°ÓÐÂÄÀúÁ¨  £¬Äã½ÐЧÀÍ֮ǰÂï  £¬Òª°Ñ¼ÒÀïÇéÐν²ÇåÎú  £¬ÌØÊâÊÇʲرµØ·½»µÁË  £¬Ê²Ø±¹¤¾ßÐèÒª´ø¡£ƒÓȻʦ¸µ´øƒÓ´øÆë¹¤¾ß  £¬Íù·µÅÜ  £¬ÆÌÕÅʱ¼äÄãÒ²·³¡£ÉÏ»ØÎÒÇëÈËÀ´ÐÞ¿Õµ÷  £¬Ã»Ìáǰ½²  £¬Ð§¹ûËûÅÜÁËÁ½ÌË  £¬×îºó¶à»¨ÁËʱ¼ä»¹¶à»¨ÁËÇ®  £¬ƒÓ»®ËãÁ¨¡£

ÉÏÃÅЧÀÍÒ²ÓÐȤ  £¬½¨ê±Î¶µÀ²ØÔÚÀïÍ·

Äã˵Âï  £¬Õ⡸¸¶·ÑЧÀÍͬ³ÇÉÏÃÅ¡¹²»µ«ÊDZ㵱  £¬»¹ÄÜ¿´µ½°³½¨ê±µÄζµÀ¡£ÉÏ»ØÎÒ½ÐÈËÀ´ÐÞË®¹Ü  £¬±Ë¸öʦ¸µÊǽ¨ê±ÍâµØÈË  £¬»¹¸úÎÒ½²ËûСʱ¼äÔÚ°³ÀÏÏïÀïÍæË®µÄÊÂÁ¨¡£½²×޲×Å  £¬É¶Ê±½ÚË®¹ÜÐÞÄÀÁ˶¼ƒÓ×¢ÖØ¡£Äã½²  £¬ÊDz»ÊÇÓÐÒâ˼£¿

ÉÐÓÐÂï  £¬ÉÏÃÅЧÀÍÓÐʱ»¹ÄÜÓöµ½ÊìÈË¡£±ËÈÕÎҽиöʦ¸µÀ´Ï´åªÓÍÑÌ»ú  £¬Ð§¹ûÒ»¿ªÃÅ  £¬àë  £¬ÊÇÎÒºóÉúʱ½ÚµÄÀÏͬÑâ¡£Ëû½²  £¬ÏÖÔÚ×öÕâÐÐͦºÃµÄ  £¬¼ûµ½ÀÏÅóÙ­Ò°¿ªÐÄ¡£°²ÄØÄã˵  £¬ÕâÉÏÃÅЧÀÍÊDz»ÊÇÉÐÓеãÈËÇéζÁ¨£¿


»°½²µ½Õâ  £¬Äã¿ÉÄÜÒªÎÊÁ¨¡­¡­

Ïà¹ØÍ¼Æ¬

ÎÊ£º½ÐÉÏÃÅЧÀÍ  £¬Ôõô²Å»ª×îÊ¡ÐÄ£¿

´ð£ºÚÀ  £¬ÕÕÎÒ¿´àë  £¬µÚһѡ¿¿Æ×µÄƽ̨»òÍâµØÊ¦¸µ  £¬µÚ¶þÌáǰ°ÑÇéÐν²ÇåÎú  £¬µÚÈýÂï  £¬ÐÄ̬·ÅºÃ  £¬ƒÓҪ̫¼±¡£°²ÄؾͶÔÁ¨¡£

±êÇ©£º

  • ½¨ê±¸¶·ÑЧÀÍ
  • ͬ³ÇÉÏÃÅ
  • ÀϽ¨ê±ÉúÑÄ
  • ¼Ò¾ÓÐÞÀí
  • ½¨ê±Î¶µÀ

¡¶À¥Ã÷¸ß¶Ë²èspa»áËù¡·

»¨·Û¹ýÃôÊÇÓÉÖÂÃô»¨·ÛÓÕ·¢µÄ¢ñÐÍʧ³£·´Ó¦ÐÔ¼²²¡¡£»¨·Û¹ýÃôµÄ¡°ÔªÐס±Ö¸µÄ¾ÍÊÇÕâÀïËù˵µÄÖÂÃô»¨·Û  £¬ËüÒ»Ñùƽ³£ÒÔ·çý»¨·Û¾Ó¶à¡£

¡¶Æ½ÑôСºúÍ¬ÍÆÄõ꡷

ÊÔµãÒ»Äê¶àÀ´  £¬80ÌõÊԵ㲽·¥ÒÑ»ù±¾Â䵨  £¬¿ªÕ¹ÁËÒ»ÅúÒýÁìÐÔ¡¢±ê¼ÇÐÔÖÆ¶ÈÁ¢Òì¡£ÉϺ£Êý¾ÝÉúÒâËù½¨Óñ³É¹úÊ×ÌõÊý¾ÝÉúÒâͬÃËÁ´  £¬Áè¼Ý100¸öÊý¾Ý²úÆ·¹ÒÅÆÉúÒ⣻½¨ÉèÍâ×ÊÆóÒµ±ê×¼»¯Ð­×÷ƽ̨  £¬Ö§³ÖÍâ×ÊÆóÒµÒ»ÂɼÓÈë±ê×¼ÖÆÐÞ¶©£»¼ÓËÙ¹ú¼ÊÖÐת¼¯Æ´ÖÐÐĽ¨Éè  £¬ÖÐת»õÎï¿¿¸ÛÖÁ³öÔËʱ¼äËõ¶Ì50%¡£ÉÌÎñ²¿ÌåÏÖ  £¬½«»áͬÓйط½ÃæÒ»Á¬ÍƽøÊԵ㲽·¥ÖÜÈ«Â䵨ÊÕЧ  £¬¹ØÓھ߱¸Ìõ¼þµÄÊԵ㲽·¥  £¬ÊµÊ±¸´ÖÆÍƹãÖÁ¸ü´ó¹æÄ£¡£

¡¶¿ª·âÀͶ¯Â·ÍÆÄõêЧÀÍÁ÷³ÌÏê½â¡·

2026ÄêÊǹ«Ë¾²úÆ··ÅÁ¿´óÄê  £¬½¹µã²úÆ·Sac-TMT£¨SKB264£©¡¢Tagitanlimab£¨A167£©¡¢Cetuximab N01£¨A140£©Èý¿î²úÆ·Ê×´ÎÀÖ³ÉÄÉÈë¹ú¼ÒÒ½±£Ä¿Â¼²¢×Ô2026Äê1ÔÂ1ÈÕÆðÉúЧ  £¬Í¬Ê±ÒÑÍêÓñ³É¹ú31¸öÊ¡·Ý¹ÒÍø¡£±¨¸æÖ¸  £¬¹«Ë¾ÉÌÒµ»¯ÏµÍ³Òѳõ¾ßЧ¹û  £¬Îª2026Äê·ÅÁ¿µÓÚ¨»ù´¡¡£²úÆ·ÒÑÁýÕÖ³¬300¸ö¶¼»á¡¢1200¼ÒÒ½ÁÆ»ú¹¹¼°400¼ÒDTPÒ©·¿¡£ÉÌÒµ»¯ÍŶÓÒÑÀ©ÕÅÖÁ600ÈËÒÔÉÏ  £¬²¢Íê³Éרҵ»¯·Ö¹¤¼°ÏµÍ³´î½¨¡£2025ÄêΪ֧³Ö²úÆ·ÏúÊÛ  £¬ÏúÊÛÓöÈͬ±È¼¤Ôö160.1%ÖÁ4.75ÒÚÔªÈËÃñ±Ò  £¬µ¼Öµ÷½âºóÄê¶È¿÷ËðΪ2.11ÒÚÔª  £¬µ«¹«Ë¾ÔÚÊÖÏֽ𼰽ðÈÚ×ʲú³äÔ£  £¬´ï45.59ÒÚÔª¡£

¡¾ÍøÕ¾µØÍ¼¡¿¡¾sitemap¡¿